secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001193125-25-035114
Event type: other_material
Sentiment:  neutral
Materiality: 0.04
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics stockholders elect two Class II directors and ratify KPMG as auditor
--------------------------------------------------------------------------------

- Lawrence Alleva elected with 27,501,778 votes for, 3,359,405 withheld, 10,682,973 broker non-votes.
- Kevin Lokay elected with 27,504,038 votes for, 3,357,145 withheld, 10,682,973 broker non-votes.
- KPMG LLP ratified as independent auditor for FY2024 with 41,342,291 for, 184,580 against, 17,285 abstentions.
- Annual meeting held on February 24, 2025; all proposals approved by stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312525035114/0001193125-25-035114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312525035114/d830385d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-035114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer